Target intelligence / Profile preview

Platymonas subcordiformis Channelrhodopsin CatCh2.0 (PsCatCh2.0)

Target
PsCatCh2.0
Molecular classification
Microbial opsin, Light-gated ion channel, Cation channel
01

Overview

PsCatCh2.0 is an engineered, light-gated cation channel derived from the microbial opsin of the green alga Platymonas subcordiformis, specifically optimized for optogenetic vision restoration (Bionic Sight, 2021; Govorunova et al., 2013). It is designed to be expressed in retinal ganglion cells (RGCs) via adeno-associated virus (AAV) delivery, allowing these cells to function as primary photosensors in the absence of healthy rods and cones (ClinicalTrials.gov, NCT04278131). The CatCh (Calcium-transmitting Channelrhodopsin) modification significantly increases the channel's calcium permeability and light sensitivity, enabling activation at lower light intensities while maintaining the fast kinetics necessary for high-resolution temporal vision (Kleinlogel et al., 2011). The 2.0 version incorporates further proprietary optimizations for enhanced protein expression and membrane trafficking in human neurons (Bionic Sight, 2021). By facilitating light-induced membrane depolarization and subsequent neural firing, PsCatCh2.0 restores the retina's ability to transmit visual signals to the brain in patients with advanced retinitis pigmentosa (Bionic Sight, 2021). This optogenetic approach represents a significant advancement in treating profound blindness by targeting surviving downstream neurons rather than attempting to repair or replace damaged photoreceptors (ClinicalTrials.gov, NCT04278131).

Other names
PsChR-L132CPlatymonas subcordiformis channelrhodopsin variantCatCh2.0PsCatCh
02

Mechanism of action

Light-activated cation influx leading to depolarization of retinal ganglion cells

03

Biological functions

PhototransductionMembrane depolarizationCation transport
04

Disease associations

Retinitis pigmentosaPhotoreceptor degenerationBlindness
05

Safety considerations

Immunogenicity of algal proteinAAV-mediated intraocular inflammation (uveitis)Phototoxicity from high-intensity light stimulationPotential for off-target expression in non-RGC retinal cells
06

Interacting drugs

BS01
07

Biomarkers

Visual acuity (LogMAR)Visual Evoked Potentials (VEP)Light sensitivity thresholdsOrientation and Mobility (O&M) testing

Beyond the preview

Go deeper on Platymonas subcordiformis Channelrhodopsin CatCh2.0 (PsCatCh2.0).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platymonas subcordiformis Channelrhodopsin CatCh2.0 (PsCatCh2.0).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call